Global Biobanking Market to Reach US$ 77.6 Billion by 2027, Impelled by Growing Prevalence of Infectious and Chronic Diseases

March 21, 2022

The latest report by IMARC Group, titled “Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” finds that the global biobanking market size reached US$ 53.3 Billion in 2021. Biobanking refers to the procedure of collecting and preserving human biospecimens that can be further used for diagnosis, biodiversity studies, and research. These specimens are stored for several years and are used by multiple researchers for cross-purpose research studies and to improve the understanding of health and different diseases. Over the years, biobanking has become a vital resource in medical research, supporting various types of contemporary research like genomics and personalized medicine.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Biobanking Market Trends:

The market is primarily driven by the growing prevalence of infectious and chronic diseases as biobanking is extensively used to develop diagnostics that can accurately and quickly identify pathogens. In addition, the escalating demand for regenerative medicine and personalized treatment represents another major growth-inducing factor. Besides this, health agencies of numerous countries are investing in virtual biobank network models that help investigators locate biospecimens and data mining from multiple biobanks. This, coupled with the significant developments in genomics, disease biology, metagenomics, proteomics, bioenergy, and environmental remediation, are positively influencing the market growth. Moreover, key players are integrating various advanced technologies with biobanking that assists healthcare professionals in collecting high-quality and well-annotated human biospecimens, and understanding pathogenic mechanisms. These advanced methods are also being utilized to identify therapeutic targets of coronavirus disease (COVID-19), which is also creating a positive market outlook across the globe. Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, expanding at a CAGR of 6.18% during the forecast period (2022-2027).

Market Summary:

  • Based on the specimen type, the market has been categorized into blood products, solid tissue, cell lines, nucleic acid, and others.
  • On the basis of the biobank type, the market has been bifurcated into population-based and disease-oriented biobanks.
  • Based on the application, the market has been classified into therapeutics and research.
  • On the basis of the end user, the market has been segmented into academic institutions, and pharma and biotech companies.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined, with some of the key players being Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, LLC, Ctibiotech, Cureline Inc., Firalis S.A., Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc. and VWR Corporation (Avantor Inc.).

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Global Biobanking Market to Reach US$ 77.6 Billion by 2027, Impelled by Growing Prevalence of Infectious and Chronic Diseases
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More